Insights

In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.

Pharmatica image of a Pharmaceutical research laboratory illustrating Good Laboratory Practice, controlled experiments, documentation, and data integrity in preclinical R&D.

Preclinical Development Biomedical R&D Pharma Policy

Good Laboratory Practice Always Sets the R&D Standard

Nicole Dale

Pharmatica image representing the AlphaGenome Atlas genomic AI map with single-nucleotide variant prediction across the human genome.

AI Drug Discovery AI & Machine Learning Research Informatics

AlphaGenome Atlas: Mapping Every Possible DNA Variant

Nicole Dale

Pharmatica image showing planning for FDA Expedited IND Pilot application to support faster preparation for first-in-human clinical trials.

Regulatory Pathways Regulatory Strategy Clinical Trial Regulation

FDA Expedited IND Pilot Targets Faster First-In-Human Trials

Nicole Dale

Pharmatica close-up image of a young child wearing a white T-shirt with a Rare Disease Day badge, seated in a bright clinical home environment with red medical devices in the background, representing rare disease care, patient independence, and humanitarian medical technology.

CDRH Rare Disease Impact Initiative Sets New FDA Focus

Pharmatica image of an ADC manufacturing facility showing antibody-drug conjugate drug product production and pharmaceutical processing equipment.

More Than Conjugation: ADC Manufacturing

Pharmatica GLP-1 obesity clinical development visual showing metabolic therapy, clinical research, and evidence generation.

GLP-1 Obesity Evidence Is Changing Clinical Development

Pharmatica editorial close‑up of FDA regulatory submission materials for diabetes devices, featuring a Libre glucose sensor, red insulin pen, and red office stamps and pens on a beige folder labeled, ‘U.S. Food & Drug Administration (FDA) – Regulatory Submission Diabetes Division,’ representing medical‑device approval and diabetes‑management technology.

Libre Duo FDA Authorisation Through De Novo Pathway

Explore All Insights

Browse our complete library of expert articles and analysis. Explore content across science, policy and life sciences innovation.

Nicole Dale

Deep Learning in Clinical Trials for 2026 and Beyond

Pharmatica representation of deep learning in clinical trials, especially AI‑driven patient recruitment in clinical trials with a realistic laboratory setting and data visualisations, global site maps, and trial analytics dashboards illustrating machine learning in clinical trials, patient recruitment AI, and adaptive trial design AI.

Deep learning is changing how clinical trials are designed, run, and analysed in 2026. Examine the tools, outcomes, and strategic risks shaping adoption.

Nicole Dale

GLP-1 Drug Discovery Success Transformed Pharmaceutical R&D

Pharmatica photorealistic illustration of GLP-1 drug discovery showing peptide molecules, metabolic signalling pathways, and obesity treatment research in a modern pharmaceutical laboratory.

From gut hormones to global therapeutics, GLP-1 drug discovery transformed obesity treatment through peptide engineering and incretin biology translation.

Nicole Dale

FDA PreCheck Pilot Program to Build Manufacturing Readiness

Pharmatica image of regulatory inspectors reviewing digital drug manufacturing systems in a pharmaceutical production facility, illustrating the FDA PreCheck Pilot Program, manufacturing readiness, U.S. domestic drug manufacturing, and advanced pharmaceutical manufacturing.

The FDA PreCheck Pilot Program aims to strengthen U.S. domestic drug manufacturing through regulatory engagement, manufacturing readiness, and advanced production.

Nicole Dale

AI and Neuroscience. Why Big Pharma Is Betting on the Brain

Pharmatica’s AI in neuroscience graphical concept showing a digital brain connected to pharmaceutical research, precision psychiatry, biomarkers, and advanced artificial intelligence technologies.

AI in neuroscience is driving big pharma investment. Discover how AI neuroscience platforms are driving precision psychiatry and psychedelic therapeutics.

Nicole Dale

FDA Master Protocol Guidance for Smarter Clinical Trials

Clinical research laboratory featuring a Master Protocol document, laboratory samples, and digital analytics, representing clinical trial efficiency for precision medicine research under the FDA Master Protocol guidance.

Explore the FDA's Master Protocol guidance and how basket, umbrella, and platform trials can improve clinical trial efficiency, especially in oncology and biologics.

Nicole Dale

Can Deep Learning Survive the Precision Medicine Paradox?

High‑resolution laboratory data visualisation screen showing molecular structures, DNA helix, and genomic charts in green and sunshine yellow against a clean white background, symbolising precision medicine and advanced drug discovery.

As precision medicine narrows patient cohorts to rare‑disease scales, deep learning models face a paradox of data scarcity and overfitting that threatens the future of clinical AI.

Nicole Dale

Operation TrialBlazer: Can the U.S. Reclaim Clinical Trial Leadership?

Operation TrialBlazer aims to reshape U.S. clinical trials by combining FDA regulatory innovation, digital technologies, and modern trial strategies to reclaim global leadership in pharmaceutical development.

Operation TrialBlazer aims to reignite U.S. clinical development by accelerating trials, modernising FDA oversight, and strengthening pharmaceutical innovation.

Nicole Dale

Genomic Governance Ensures Equity at the Core of Drug Discovery

Scientists analysing diverse genomic datasets to support genomic equity, AI-driven drug discovery, and precision medicine in pharmaceutical research.

Discover why genomic equity is essential for reliable AI-driven drug discovery, precision medicine, and building more representative pharmaceutical innovation.

Nicole Dale

FDA Registration for Drug Manufacturing Enters a New Era

Modern pharmaceutical manufacturing facility with stainless steel equipment, automated vial conveyor, and red digital data wave overlay symbolising FDA regulatory oversight and digital quality systems.

The FDA's proposed drug manufacturing modernisation rule could accelerate distributed manufacturing, digital quality systems, and pharma supply chain resilience.

Nicole Dale

AAV Vector Manufacturing: Solving Gene Therapy's Bottleneck

Scientist’s gloved hands handling a vial and pipette in a bright laboratory with a glowing DNA helix and AAV capsid, representing advanced AAV vector manufacturing and gene therapy process development.

Discover how innovations in AAV vector manufacturing are improving scalability, quality, and commercial readiness for next-generation gene therapies.

Nicole Dale

11 Clinical Trials Defining Pharmaceutical Strategy in 2026

The top 11 clinical trials 2026 highlighting breakthrough pharmaceutical innovations across obesity, gene editing, cardiovascular disease, psychiatry, and rare diseases.

We've mapped the competitive, regulatory, and commercial stakes of the top 11 clinical trials that have defined pharma strategy so far in 2026.

Nicole Dale

Anthropic’s Big AI Drug Discovery Announcement

Anthropic drug discovery programme combines AI research with pharmaceutical R&D as a scientist uses advanced analytics to accelerate neglected disease drug discovery.

Anthropic's new drug discovery programme marks a strategic shift from sole AI software provider to active R&D participant. Here's what it means for pharmaceutical innovation.

Topic